Publication | Closed Access

Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals

Healthy Elderly IndividualsAlzheimer's DiseaseAgingGeriatricsDementiaVascular DementiaLower LevelsNeurochemical BiomarkersNeurologyAlzheimer DiseaseAging-associated DiseaseMedicineLewy Body Dementia